Clinical Trials Directory

Trials / Completed

CompletedNCT00406692

The Effects of Zonisamide on Alcohol Dependence

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Boston University · Academic / Other
Sex
All
Age
21 Years – 64 Years
Healthy volunteers
Not accepted

Summary

In this study the influence of zonisamide administration over a 13 week period on alcohol consumption in alcoholic (alcohol dependent) subjects will be examined. The dose of zonisamide given to subjects will be slowly increased over a period of several weeks. They will receive a full dose over a 5 week period. This will be a pilot study in which all of the subjects will only receive zonisamide. A primary objective of this study is to determine the possible size of the effect that zonisamide administration has on drinking (i.e. drinks consumed per day) to allow us to plan for a larger clinical trial of the effects of zonisamide on alcohol dependence.

Conditions

Interventions

TypeNameDescription
DRUGZonisamideWeek 1 (Wk1) -100 mg daily; Wk 2- 100 mg daily; Wk 3- 200 mg daily; Wk 4- 200 mg daily; Wk 5- 300 mg daily; Wk 6- 300 mg daily; Wk 7-11- 400 mg daily; Wk 12(Days 1-5) 300 mg daily; Wk 12 (Day 6-7) Week 13 (Days 1-3)- 200 mg daily; Week 13 (Days 4-7) - 100 mg daily.

Timeline

Start date
2006-11-01
Primary completion
2008-08-01
Completion
2009-11-01
First posted
2006-12-04
Last updated
2010-05-11
Results posted
2010-05-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00406692. Inclusion in this directory is not an endorsement.